Acute Coronary Syndrome (ACS) Significantly Increases After mRNA COVID-19 Vaccine, Researchers Warn

Share

The risk of developing acute coronary syndrome (ACS) significantly increased in patients after receiving mRNA COVID-19 vaccines.

PUBLISHED RESEARCH LINK: https://www.ahajournals.org/doi/abs/10.1161/circ.144.suppl_1.10712

This group of researchers are using a validated test, which is based on biological markers and which can predict the risk of an acute coronary syndrome within 5 years. This study concerns a population of 566 individuals aged 28 to 97 years, followed for 8 years already in a longitudinal study, a type of study which allows researchers to detect evolutions or changes in the characteristics of the target population at the same time at the group level and at the individual level.

The risk of a 5-year cardiac event observed before vaccination was 11% over this 8-year period. After the COVID vaccination, this risk rose to 25%, which is a huge increase!

British Dr John Campbell looks at the American Heart Association journal’s recent pre-publication research & concludes that – if true – we are at risk of getting an unimaginable amount of extra heart attacks
Using the PULS Cardiac Test, which measures multiple protein biomarkers, researchers were able to generate a score that predicts the 5-year risk of developing acute coronary syndrome.

This is not about comparing groups of individuals as in a randomized controlled trial, which may introduce confounding factors. As each patient serves as his own control, these confounding factors are eliminated and the results obtained are therefore very robust. These clinical observations are consistent with pharmacovigilance data which show a dramatic increase in thrombosis, cardiomyopathy and other vascular events following vaccination.

At the time of this report, these changes persist for at least 2.5 months after the second dose of vaccine. If these changes were to persist over time, we can expect a veritable epidemic of heart attacks in the years to come, in the order of many tens of thousand heart attacks above the norm over 5 years for a country the size of Belgium.

In a November 21, 2021, tweet, cardiologist Dr. Aseem Malhotra writes:1

“Extraordinary, disturbing, upsetting. We now have evidence of a plausible biological mechanism of how mRNA vaccine may be contributing to increased cardiac events. The abstract is published in the highest impact cardiology journal so we must take these findings very seriously.”

These changes may subside in the months that follow, but in all likelihood taking any additional dose could only increase the risk of acute coronary syndrome even further.

There is only one conclusion: it is absolutely necessary to stop the vaccination campaign. And for those who are already vaccinated, it is important not to do a third dose. Primum non nocere: first do no harm. Let us remember that a heart attack is fatal 90% of the time!

“We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.”

Below is the original abstract reproduced in its entirety:

Our group has been using the PULS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS). The score is based on changes from the norm of multiple protein biomarkers including IL-16, a proinflammatory cytokine, soluble Fas, an inducer of apoptosis, and Hepatocyte Growth Factor (HGF)which serves as a marker for chemotaxis of T-cells into epithelium and cardiac tissue, among other markers. Elevation above the norm increases the PULS score, while decreases below the norm lowers the PULS score.The score has been measured every 3-6 months in our patient population for 8 years. Recently, with the advent of the mRNA COVID 19 vaccines (vac) by Moderna and Pfizer, dramatic changes in the PULS score became apparent in most patients.This report summarizes those results. A total of 566 pts, aged 28 to 97, M:F ratio 1:1 seen in a preventive cardiology practice had a new PULS test drawn from 2 to 10 weeks following the 2nd COVID shot and was compared to the previous PULS score drawn 3 to 5 months previously pre- shot. Baseline IL-16 increased from 35+/-20 above the norm to 82 +/- 75 above the norm post-vac; sFas increased from 22+/- 15 above the norm to 46+/-24 above the norm post-vac; HGF increased from 42+/-12 above the norm to 86+/-31 above the norm post-vac. These changes resulted in an increase of the PULS score from 11% 5 yr ACS risk to 25% 5 yr ACS risk. At the time of this report, these changes persist for at least 2.5 months post second dose of vac.We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.